The Africa Patient Safety Summit (APSS) Leadership Forum convened by Medicines for Africa (mfa) in partnership with the African Medicines Agency (AMA) is under way at AMA HQ in Kigali, Rwanda. Over two days, experts will assess the state of patient safety across Africa and leave with clear, actionable next steps to strengthen it. #PatientSafetyWeek #AMA #mfa

Happening now: Director-General of AMA, H.E. Dr Delese Mimi Darko speaking on the Infectious Disease R&D: From breakthroughs to leadership for the next decade panel at Wellcome’s Health Wonders: Changing lives through science in London, UK.

We’re proud to announce that the African Medicines Agency (AMA) has signed an MoU with @USPharmacopeia (USP)! This partnership will strengthen regulatory systems, advance harmonization, and expand access to safe, effective, and quality-assured medicines across Africa. The AMA is also pleased to join the USP Convention, contributing to global standards and collaboration to strengthen trust in medical products. This strategic partnership is building stronger, more coordinated health systems for the continent. Read more at au-ama.africa/news_events/am… #AMA #HealthSecurity #GlobalHealthPartnerships

Today in Johannesburg, the Director General of the African Medicines Agency (AMA), Dr Delese Mimi Darko, delivered the keynote address at the opening of the USP Africa Regional Chapter Meeting. Speaking under the theme “Partnering for Progress: Localisation and Building Regulatory Capacity for Next-Gen Medicines in Africa,” she underscored a critical point: Africa has regulatory and technical capacity, but this is not yet fully connected. AMA’s mandate is to connect this existing capacity, foster effective collaboration among National Regulatory Authorities (NRAs), and serve as an enabler for coordinated, continent-wide regulatory strengthening. Dr Darko highlighted the tremendous progress Africa has made in medicines regulation and reaffirmed AMA’s commitment to ensuring this progress is sustained, harmonised, and future-ready, in close partnership with NRAs and institutions such as USP. Strong partnerships will be key to delivering safe, quality, next-generation medicines for Africa.

Today, following a joint guidance from the Director-General of AMA, Dr Delese Mimi Darko and the Director-General of Africa CDC, Dr Jean Kaseya core technical staff of AMA and Africa CDC met to align on three priority areas namely: 1. Develop a continental quality assurance policy to guide procurement under the African Pooled Procurement Mechanism 2. ⁠Agree on procedures for prioritization of medical products for continental listing. 3. ⁠ Coordinate support to local manufacturers on the continent through the complementary activities of the AMA SME & Innovation Office and the Africa CDC Business Acumen Facility. Both institutions are pleased to be working together to advance health sovereignty through a robust, harmonized, and resilient health infrastructure, driving stronger systems, greater coordination, and improved health outcomes across the continent. #QualityAssurance #AHSS #AfricanManufacturing #AMA #AfricaCDC

On Wednesday, 8 April 2026, H.E. Dr Delese Mimi Darko, Director General of the African Medicines Agency (AMA), paid a courtesy visit to Dr Fiona Braka, Country Representative to @WHOGhana . The meeting focused on progress in AMA’s operationalisation and explored opportunities for collaboration to enhance regulatory capacity and performance in Ghana and across Africa.

Why Stronger Medical Products Regulation Is Essential to Drive Africa’s Health Investments At #UNECA58, AMA DG H.E. Dr. Delese Mimi Darko highlighted a key message: “Health financing delivers impact only when regulatory systems are coordinated and trusted” Fragmented pathways slow approvals and delay access. AMA’s continental approach streamlines reviews, strengthens reliance, and ensures Africa’s investments translate into timely, safe, quality-assured medical products. Stronger regulation = smarter investment + better access for patients across Africa. #MedicalProductsRegulation #AMA #AfricaHealth #HealthFinancing #Tangier

H.E. Dr Delese Mimi Darko, Director-General of the African Medicines Agency (AMA), delivered a keynote address at the West Africa Biomanufacturing Regulation & Market Access Forum, calling for stronger regulatory coordination to support Africa’s growing biomanufacturing sector and ensure access to safe, quality and efficacious medicines on the continent. “Africa’s biomanufacturing future will be defined not by ambition alone, but by whether we build systems that work: systems that regulators trust, industry can navigate, and patients can rely on."

Today, H.E. Dr Delese Mimi Darko (AMA) met H.E. Dr Jean Kaseya (Africa CDC) in Addis Ababa to reaffirm joint action, clarify complementary mandates, and boost cooperation in areas like pooled procurement and AfCFTA-linked health trade. #Africa #AMA #AfricaCDC #HealthSecurity